Can anyone shed light on how long chemotherapy remains effective on the average?
Chemotherapy Effectiveness - Advanced Prostate...
Chemotherapy Effectiveness
For mCRPC or mHSPC?
Based on a recent clinical trial comparing Cabazitaxel chemotherapy with switching anti-androgens: "The median imaging-based progression-free survival was 8.0 months with cabazitaxel and 3.7 months with the androgen-signaling–targeted inhibitor."
nejm.org/doi/full/10.1056/n...
Wasn’t that just for the imaging progression? The overall survival being 13.6 and 11 month’s respectively?
‘The median imaging-based progression-free survival was 8.0 months with cabazitaxel and 3.7 months with the androgen-signaling–targeted inhibitor. The median overall survival was 13.6 months with cabazitaxel and 11.0 months with the androgen-signaling–targeted inhibitor (hazard ratio for death, 0.64; 95% CI, 0.46 to 0.89; P=0.008).’
When I became castrate-resistant, my treatment changed. Lupron was continued. Zytiga was added. Six rounds of Jevtana were endured.
The last chemo was in the first week of March 2021. Now 22 months later, I am still on Lupron and Zytiga and my PSA is still just barely detectable. Scans every three months continue to show no growing mets, no new mets.
So far so good.
Thanks. I'm curious, as someone who actually has advanced prostate cancer (thanks for sharing the details in your profile), was it worth doing for you to stay alive? That's the bottom line. For me, the answer to that question is YES.
Absolutely yes. My back pain was very bad. Eight out of ten at one point, before I started treatment. My back pain has been at zero or one for over three years now.
Chemo is next SOC for me if things get worse and I decide to get it. After seeing all the comments about lower side effects with Cabazitaxel versus Docetaxal, I looked up both. From the relatively current requirements I found, SOC is to start with Docetaxal and only after failure of that can you get Cabazitaxel. Any other info on that?
I’d be interested to know also. My husband had Docetaxal in 20/21, has become castrate resistant after both Bicalutamide and Abiraterone stopped working. Thought he was going to qualify for BAT but don’t think that’s going to happen now. MO says next possibility is more chemo but she hasn’t said if they’ll try the Docetaxal again or a different chemo med
They like to wait a while before rechallenging chemo. But if he had it in 20/21, that's long enough providing the doctor thinks it was working. Usually that involves looking at the PSA rise or fall after stopping chemotherapy. My doctor told me if the PSA goes back up within 6 months after stopping chemotherapy, he doesn't think it's worth rechallenging. That was the case with me, so we moved on to Cabazitaxel.
Was the BAT going to be in a clinical trial, or was it going to be done independently by your MO (by following trial protocols)?
I believe it was going to be done by his MO following trial protocols.
But alas, he won’t be in the BAT trial after all. His MO called yesterday with the news that my husband’s PSA has doubled in the last month so she wants him to have more chemo treatments to get him back under control. This time they’ll give him Cabazitaxal. He says he’s okay with it, just hates losing his hair again